SLU-PP-332 is a small-molecule pan-agonist of the estrogen-related receptors (ERRα/β/γ), developed as an "exercise mimetic" research tool studied for reproducing parts of the metabolic response normally triggered by endurance exercise.
Animal data only
SLU-PP-332 is a small synthetic molecule (not technically a peptide, despite being sold alongside them) that activates estrogen-related receptors. Researchers call it an "exercise mimetic" because in mice it increases mitochondrial content, shifts muscle fiber composition toward fatigue resistance, and improves stamina/fat loss without the animal actually exercising more. It was created as a lab tool to study exercise biology, not developed toward human use — no human trials exist.
What is SLU-PP-332 researched for?+
Reproducing exercise-like metabolic effects (endurance and mitochondrial signaling) through ERR receptor activation, without physical exercise.
Is SLU-PP-332 FDA-approved?+
No. As of 2026 it has no FDA approval and no Investigational New Drug application on file — it remains a research tool compound with no clinical development program.
Is SLU-PP-332 a peptide?+
No, it is a small molecule, not a peptide.
How can something 'mimic exercise'?+
It activates the same receptors (ERR-alpha, beta, gamma) your body naturally activates during aerobic exercise, triggering genes tied to mitochondrial growth, fat burning, and endurance adaptation — without the actual exercise.
Does it actually work in real studies?+
In mice, genuinely well — increased endurance, more fat-burning muscle fiber, reduced fat mass, improved insulin sensitivity. Human research is early, and it isn't FDA-approved for anything.
Looking for something specific, or placing a wholesale order? Send us a DM or email.